Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239499 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium
DRUG: Salmeterol plus Fluticasone

Sponsor

Boehringer Ingelheim